Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human POR gene: a structural and functional impact

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Agrahari, A. K., Doss, G. P. C., Siva, R., Magesh, R., & Zayed, H. (2019). Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson’s disease: A molecular dynamics simulation approach. Journal of Theoretical Biology, 469, 163–171. https://doi.org/10.1016/j.jtbi.2019.03.003
   PubMed Web of Science ®Google Scholar
• Agrahari, A. K., Kumar, A., R, S., Zayed, H., & George Priya Doss, C. (2018). Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot-Marie-tooth disease: A computational study. Journal of Theoretical Biology, 437, 305–317. https://doi.org/10.1016/j.jtbi.2017.10.028
   PubMed Web of Science ®Google Scholar
• Agrahari, A. K., Muskan, M., George Priya Doss, C., Siva, R., & Zayed, H. (2018). Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: A molecular modeling and dynamics approach. Metabolic Brain Disease, 33(5), 1443–1457. https://doi.org/10.1007/s11011-018-0251-1
   PubMed Web of Science ®Google Scholar
• Agrawal, V., Choi, J. H., Giacomini, K. M., & Miller, W. L. (2010). Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenetics and Genomics, 20(10), 611–618. https://doi.org/10.1097/FPC.0b013e32833e0cb5
   PubMed Web of Science ®Google Scholar
• Agrawal, V., Huang, N., & Miller, W. L. (2008). Pharmacogenetics of P450 oxidoreductase: Effect of sequence variants on activities of CYP1A2 and CYP2C19. Pharmacogenetics and Genomics, 18(7), 569–576. https://doi.org/10.1097/FPC.0b013e32830054ac
   PubMed Web of Science ®Google Scholar
• Ali, S. K., Sneha, P., Priyadharshini Christy, J., Zayed, H., & George Priya Doss, C. (2017). Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. Journal of Biomolecular Structure & Dynamics, 35(12), 2714–2724. https://doi.org/10.1080/07391102.2016.1229634
   PubMed Web of Science ®Google Scholar
• Anbarasu, A., Veeraraghavan, B., Vasudevan, K., Basu, S., Arumugam, A., Naha, A., & Ramaiah, S. (2021). Identification of potential carboxylic acid-containing drug candidate to design novel competitive NDM inhibitors: An in-silico approach comprising combined virtual screening and molecular dynamics simulation. https://doi.org/10.1101/2021.07.05.451101
   Google Scholar
• Arlt, W. (2007). P450 oxidoreductase deficiency and Antley-Bixler syndrome. Reviews in Endocrine & Metabolic Disorders, 8(4), 301–307. https://doi.org/10.1007/s11154-007-9056-y
   PubMed Web of Science ®Google Scholar
• Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., Stewart, P. M., & Shackleton, C. H. L. (2004). Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: Analytical study. Lancet (London, England), 363(9427), 2128–2135. https://doi.org/10.1016/S0140-6736(04)16503-3
   PubMed Web of Science ®Google Scholar
• Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016). ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Research, 44(W1), W344–350. https://doi.org/10.1093/nar/gkw408
   PubMed Web of Science ®Google Scholar
• Bai, Y., Li, J., & Wang, X. (2017). Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: Case report and literature review. Journal of Ovarian Research, 10(1), 16. https://doi.org/10.1186/s13048-017-0312-9
   PubMedGoogle Scholar
• Basu, S., Naha, A., Veeraraghavan, B., Ramaiah, S., & Anbarasu, A. (2022). In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein-protein and host-pathogen interaction analysis. Journal of Cellular Biochemistry, 123(1), 115–127. https://doi.org/10.1002/jcb.29953
   PubMed Web of Science ®Google Scholar
• Campelo, D., Esteves, F., Brito Palma, B., Costa Gomes, B., Rueff, J., Lautier, T., Urban, P., Truan, G., & Kranendonk, M. (2018). Probing the role of the hinge segment of cytochrome P450 oxidoreductase in the interaction with cytochrome P450. International Journal of Molecular Sciences, 19(12), 3914. https://doi.org/10.3390/ijms19123914
   PubMed Web of Science ®Google Scholar
• Campelo, D., Lautier, T., Urban, P., Esteves, F., Bozonnet, S., Truan, G., & Kranendonk, M. (2017). The hinge segment of human NADPH-cytochrome P450 reductase in conformational switching: The critical role of ionic strength. Frontiers in Pharmacology, 8, 755. https://www.frontiersin.org/article/10.3389/fphar.2017.00755 https://doi.org/10.3389/fphar.2017.00755
   PubMed Web of Science ®Google Scholar
• Capriotti, E., Altman, R. B., & Bromberg, Y. (2013). Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics, 14(Suppl 3), S2. https://doi.org/10.1186/1471-2164-14-S3-S2
   PubMedGoogle Scholar
• Capriotti, E., Calabrese, R., & Casadio, R. (2006). Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics (Oxford, England), 22(22), 2729–2734. https://doi.org/10.1093/bioinformatics/btl423
   PubMed Web of Science ®Google Scholar
• Capriotti, E., Fariselli, P., & Casadio, R. (2005). I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Research, 33(Web Server issue), W306–310. https://doi.org/10.1093/nar/gki375
   PubMed Web of Science ®Google Scholar
• Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Shaw, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., Ziaugra, L., Friedland, L., Rolfe, A., Warrington, J., Lipshutz, R., Daley, G. Q., & Lander, E. S. (1999). Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics, 22(3), 231–238. https://doi.org/10.1038/10290
   PubMed Web of Science ®Google Scholar
• Chanock, S. (2001). Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Disease Markers, 17(2), 89–98. https://doi.org/10.1155/2001/858760
   PubMed Web of Science ®Google Scholar
• Chen, C.-W., Lin, J., & Chu, Y.-W. (2013). iStable: Off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics, 14(S2), S5. https://doi.org/10.1186/1471-2105-14-S2-S5
   PubMed Web of Science ®Google Scholar
• Cheng, J., Randall, A., & Baldi, P. (2006). Prediction of protein stability changes for single-site mutations using support vector machines. Proteins, 62(4), 1125–1132. https://doi.org/10.1002/prot.20810
   PubMed Web of Science ®Google Scholar
• Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012). Predicting the functional effect of amino acid substitutions and indels. PLoS One, 7(10), e46688. https://doi.org/10.1371/journal.pone.0046688
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• David, C. C., & Jacobs, D. J. (2014). Principal component analysis: A method for determining the essential dynamics of proteins. Methods in Molecular Biology, 1084, 193–226. https://doi.org/10.1007/978-1-62703-658-0_11
   PubMedGoogle Scholar
• Esteves, F., Campelo, D., Gomes, B. C., Urban, P., Bozonnet, S., Lautier, T., Rueff, J., Truan, G., & Kranendonk, M. (2020). The role of the FMN-Domain of human cytochrome P450 oxidoreductase in its promiscuous interactions with structurally diverse redox partners. Frontiers in Pharmacology, 11, 299. https://www.frontiersin.org/article/10.3389/fphar.2020.00299 https://doi.org/10.3389/fphar.2020.00299
   PubMed Web of Science ®Google Scholar
• Fernandes, C. L., Sachett, L. G., Pol-Fachin, L., & Verli, H. (2010). GROMOS96 43a1 performance in predicting oligosaccharide conformational ensembles within glycoproteins. Carbohydrate Research, 345(5), 663–671. https://doi.org/10.1016/j.carres.2009.12.018
   PubMed Web of Science ®Google Scholar
• Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010). Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. Biochemical and Biophysical Research Communications, 401(1), 149–153. https://doi.org/10.1016/j.bbrc.2010.09.035
   PubMed Web of Science ®Google Scholar
• Flück, C. E., Nicolo, C., Pandey, A. V. (2007). Clinical, structural and functional implications of mutations and polymorphisms in human NADP H P450 oxidoreductase. Fundamental & Clinical Pharmacology, 21(4), 399–410. https://doi.org/10.1111/j.1472-8206.2007.00520.x.
   Google Scholar
• Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004). Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nature Genetics, 36(3), 228–230. https://doi.org/10.1038/ng1300
   PubMed Web of Science ®Google Scholar
• Fukami, M., & Ogata, T. (2014). Cytochrome P450 oxidoreductase deficiency: Rare congenital disorder leading to skeletal malformations and steroidogenic defects. Pediatrics International : Official Journal of the Japan Pediatric Society, 56(6), 805–808. https://doi.org/10.1111/ped.12518
   PubMed Web of Science ®Google Scholar
• George Priya Doss, C., & Zayed, H. (2017). Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metabolic Brain Disease, 32(6), 2105–2118. https://doi.org/10.1007/s11011-017-0090-5
   PubMed Web of Science ®Google Scholar
• Gromiha, M. M., An, J., Kono, H., Oobatake, M., Uedaira, H., & Sarai, A. (1999). ProTherm: Thermodynamic database for proteins and mutants. Nucleic Acids Research, 27(1), 286–288. https://doi.org/10.1093/nar/27.1.286
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Hossain, M. S., Roy, A. S., & Islam, M. S. (2020). In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions. Scientific Reports, 10(1), 1-14. https://doi.org/10.1038/s41598-020-71457-1
   Web of Science ®Google Scholar
• Huang, L.-T., Gromiha, M. M., & Ho, S.-Y. (2007). iPTREE-STAB: Interpretable decision tree based method for predicting protein stability changes upon mutations. Bioinformatics (Oxford, England), 23(10), 1292–1293. https://doi.org/10.1093/bioinformatics/btm100
   PubMed Web of Science ®Google Scholar
• Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., & Miller, W. L. (2005). Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. American Journal of Human Genetics, 76(5), 729–749. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1199364/ https://doi.org/10.1086/429417
   PubMed Web of Science ®Google Scholar
• Hubbard, P. A., Shen, A. L., Paschke, R., Kasper, C. B., & Kim, J. J. (2001). NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer. The Journal of Biological Chemistry, 276(31), 29163–29170. https://doi.org/10.1074/jbc.M101731200
   PubMed Web of Science ®Google Scholar
• Hubbard, R. E., & Haider, M. K. (2010). Hydrogen bonds in proteins: Role and strength. In ELS. American Cancer Society, https://doi.org/10.1002/9780470015902.a0003011.pub2
   Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Iyanagi, T., Xia, C., & Kim, J.-J P. (2012). NADPH-cytochrome P450 oxidoreductase: Prototypic member of the diflavin reductase family. Archives of Biochemistry and Biophysics, 528(1), 72–89. https://doi.org/10.1016/j.abb.2012.09.002
   PubMed Web of Science ®Google Scholar
• Jaenicke, R. (1995). Folding and association versus misfolding and aggregation of proteins. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 348(1323), 97–105. https://doi.org/10.1098/rstb.1995.0050
   PubMed Web of Science ®Google Scholar
• Jayaraman, M., Rajendra, S. K., & Ramadas, K. (2019). Structural insight into conformational dynamics of non-active site mutations in KasA: A Mycobacterium tuberculosis target protein. Gene, 720, 144082. https://doi.org/10.1016/j.gene.2019.144082
   PubMed Web of Science ®Google Scholar
• Jayaraman, M., & Ramadas, K. (2020). An integrated computational investigation to unveil the structural impacts of mutation on the InhA structural gene of Mycobacterium tuberculosis. Journal of Molecular Graphics & Modelling, 101, 107768. https://doi.org/10.1016/j.jmgm.2020.107768
   PubMed Web of Science ®Google Scholar
• Johnson, A. D., Handsaker, R. E., Pulit, S. L., Nizzari, M. M., O'Donnell, C. J., & de Bakker, P. I. W. (2008). SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics (Oxford, England), 24(24), 2938–2939. https://doi.org/10.1093/bioinformatics/btn564
   PubMed Web of Science ®Google Scholar
• Jolliffe, I. T., & Cadima, J. (2016). Principal component analysis: A review and recent developments. Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences, 374(2065), 20150202. https://doi.org/10.1098/rsta.2015.0202
   PubMed Web of Science ®Google Scholar
• Kandel, S. E., & Lampe, J. N. (2014). Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity. Chemical Research in Toxicology, 27(9), 1474–1486. https://doi.org/10.1021/tx500203s
   PubMed Web of Science ®Google Scholar
• Kragelund, B. B., Poulsen, K., Andersen, K. V., Baldursson, T., Krøll, J. B., Neergård, T. B., Jepsen, J., Roepstorff, P., Kristiansen, K., Poulsen, F. M., & Knudsen, J. (1999). Conserved residues and their role in the structure, function, and stability of acyl-coenzyme A binding protein. Biochemistry, 38(8), 2386–2394. https://doi.org/10.1021/bi982427c
   PubMed Web of Science ®Google Scholar
• Kumar, A., Rajendran, V., Sethumadhavan, R., Shukla, P., Tiwari, S., & Purohit, R. (2014). Computational SNP analysis: Current approaches and future prospects. Cell Biochemistry and Biophysics, 68(2), 233–239. https://doi.org/10.1007/s12013-013-9705-6
   PubMed Web of Science ®Google Scholar
• Kumar, R., Jayaraman, M., Ramadas, K., & Chandrasekaran, A. (2020). Insight into the structural and functional analysis of the impact of missense mutation on cytochrome P450 oxidoreductase. Journal of Molecular Graphics & Modelling, 100, 107708. https://doi.org/10.1016/j.jmgm.2020.107708
   PubMed Web of Science ®Google Scholar
• Maisuradze, G. G., Liwo, A., & Scheraga, H. A. (2009). Principal component analysis for protein folding dynamics. Journal of Molecular Biology, 385(1), 312–329. https://doi.org/10.1016/j.jmb.2008.10.018
   PubMed Web of Science ®Google Scholar
• Martonák, R., Laio, A., & Parrinello, M. (2003). Predicting crystal structures: The Parrinello-Rahman method revisited. Physical Review Letters, 90(7), 075503. https://doi.org/10.1103/PhysRevLett.90.075503
   PubMed Web of Science ®Google Scholar
• McCammon, K. M., Panda, S. P., Xia, C., Kim, J.-J P., Moutinho, D., Kranendonk, M., Auchus, R. J., Lafer, E. M., Ghosh, D., Martasek, P., Kar, R., Masters, B. S., & Roman, L. J. (2016). Instability of the human cytochrome P450 reductase A287P variant is the major contributor to its Antley-Bixler Syndrome-like phenotype. The Journal of Biological Chemistry, 291(39), 20487–20502. https://doi.org/10.1074/jbc.M116.716019
   PubMed Web of Science ®Google Scholar
• Mi, H., & Thomas, P. (2009). PANTHER Pathway: An ontology-based pathway database coupled with data analysis tools. Methods in Molecular Biology, 563, 123–140. https://doi.org/10.1007/978-1-60761-175-2_7
   PubMedGoogle Scholar
• Miyamoto, S., & Kollman, P. A. (1992). Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. Journal of Computational Chemistry, 13(8), 952–962. https://doi.org/10.1002/jcc.540130805
   Web of Science ®Google Scholar
• Ng, P. C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31(13), 3812–3814. https://doi.org/10.1093/nar/gkg509
   PubMed Web of Science ®Google Scholar
• Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010). Restoration of mutant cytochrome P450 reductase activity by external flavin. Molecular and Cellular Endocrinology, 321(2), 245–252. https://doi.org/10.1016/j.mce.2010.02.024
   PubMed Web of Science ®Google Scholar
• Nikam, R., Kulandaisamy, A., Harini, K., Sharma, D., & Gromiha, M. M. (2021). ProThermDB: Thermodynamic database for proteins and mutants revisited after 15 years. Nucleic Acids Research, 49(D1), D420–D424. https://doi.org/10.1093/nar/gkaa1035
   PubMed Web of Science ®Google Scholar
• P, S., Ebrahimi, E. A., Ghazala, S. A., D, T. K., R, S., Priya Doss C, G., & Zayed, H. (2018). Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2. Journal of Cellular Biochemistry, 119(9), 7585–7598. https://doi.org/10.1002/jcb.27097
   PubMed Web of Science ®Google Scholar
• Pandey, A. V., & Flück, C. E. (2013). NADPH P450 oxidoreductase: Structure, function, and pathology of diseases. Pharmacology & Therapeutics, 138(2), 229–254. https://doi.org/10.1016/j.pharmthera.2013.01.010
   PubMed Web of Science ®Google Scholar
• Pandey, A. V., & Sproll, P. (2014). Pharmacogenomics of human P450 oxidoreductase. Frontiers in Pharmacology, 5, 103. https://doi.org/10.3389/fphar.2014.00103
   PubMed Web of Science ®Google Scholar
• Parthiban, V., Gromiha, M. M., & Schomburg, D. (2006). CUPSAT: Prediction of protein stability upon point mutations. Nucleic Acids Research, 34(Web Server issue), W239–242. https://doi.org/10.1093/nar/gkl190
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014a). mCSM: Predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics (Oxford, England), 30(3), 335–342. https://doi.org/10.1093/bioinformatics/btt691
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014b). DUET: A server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Research, 42(Web Server issue), W314–319. https://doi.org/10.1093/nar/gku411
   PubMedGoogle Scholar
• Riddick, D. S., Ding, X., Wolf, C. R., Porter, T. D., Pandey, A. V., Zhang, Q.-Y., Gu, J., Finn, R. D., Ronseaux, S., McLaughlin, L. A., Henderson, C. J., Zou, L., & Flück, C. E. (2013). NADPH–cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 41(1), 12–23. https://doi.org/10.1124/dmd.112.048991
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shastry, B. S. (2007). SNPs in disease gene mapping, medicinal drug development and evolution. Journal of Human Genetics, 52(11), 871–880. https://doi.org/10.1007/s10038-007-0200-z
   PubMed Web of Science ®Google Scholar
• Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001). dbSNP: The NCBI database of genetic variation. Nucleic Acids Research, 29(1), 308–311. https://doi.org/10.1093/nar/29.1.308
   PubMed Web of Science ®Google Scholar
• Shihab, H. A., Gough, J., Cooper, D. N., Stenson, P. D., Barker, G. L. A., Edwards, K. J., Day, I. N. M., & Gaunt, T. R. (2013). Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Human Mutation, 34(1), 57–65. https://doi.org/10.1002/humu.22225
   PubMed Web of Science ®Google Scholar
• Sim, N.-L., Kumar, P., Hu, J., Henikoff, S., Schneider, G., & Ng, P. C. (2012). SIFT web server: Predicting effects of amino acid substitutions on proteins. Nucleic Acids Research, 40(Web Server issue), W452–457. https://doi.org/10.1093/nar/gks539
   PubMedGoogle Scholar
• Stierand, K., & Rarey, M. (2010). PoseView—Molecular interaction patterns at a glance. Journal of Cheminformatics, 2(S1), P50. https://doi.org/10.1186/1758-2946-2-S1-P50
   Google Scholar
• Sukumar, S., Krishnan, A., & Banerjee, S. (2021). An overview of bioinformatics resources for SNP analysis. In Advances in bioinformatics (pp. 113–135). Springer. https://doi.org/10.1007/978-981-33-6191-1_7
   Google Scholar
• Sunil Krishnan, G., Joshi, A., & Kaushik, V. (2021). Bioinformatics in personalized medicine. In Advances in Bioinformatics (pp. 303–315). Springer. https://doi.org/10.1007/978-981-33-6191-1_15
   Google Scholar
• Thirumal Kumar, D., Eldous, H. G., Mahgoub, Z. A., George Priya Doss, C., & Zayed, H. (2018). Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson’s and Gaucher diseases. Metabolic Brain Disease, 33(6), 1835–1847. https://doi.org/10.1007/s11011-018-0286-3
   PubMed Web of Science ®Google Scholar
• Venselaar, H., Te Beek, T. A. H., Kuipers, R. K. P., Hekkelman, M. L., & Vriend, G. (2010). Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics, 11(1), 548. https://doi.org/10.1186/1471-2105-11-548
   PubMed Web of Science ®Google Scholar
• Worth, C. L., Preissner, R., & Blundell, T. L. (2011). SDM—a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Research, 39(Web Server issue), W215–W222. https://doi.org/10.1093/nar/gkr363
   PubMedGoogle Scholar
• Xia, C., Panda, S. P., Marohnic, C. C., Martásek, P., Masters, B. S., & Kim, J.-J P. (2011). Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. Proceedings of the National Academy of Sciences of the United States of America, 108(33), 13486–13491. https://doi.org/10.1073/pnas.1106632108
   PubMed Web of Science ®Google Scholar
• Zaki, O. K., Krishnamoorthy, N., El Abd, H. S., Harche, S. A., Mattar, R. A., Al Disi, R. S., Nofal, M. Y., El Bekay, R., Ahmed, K. A., George Priya Doss, C., & Zayed, H. (2017). Two patients with Canavan disease and structural modeling of a novel mutation. Metabolic Brain Disease, 32(1), 171–177. https://doi.org/10.1007/s11011-016-9896-9
   PubMed Web of Science ®Google Scholar
• Zaki, O. K., Priya Doss C, G., Ali, S. A., Murad, G. G., Elashi, S. A., Ebnou, M. S. A., Kumar D, T., Khalifa, O., Gamal, R., El Abd, H. S. A., Nasr, B. N., & Zayed, H. (2017). Genotype-phenotype correlation in patients with isovaleric acidaemia: Comparative structural modelling and computational analysis of novel variants. Human Molecular Genetics, 26(16), 3105–3115. https://doi.org/10.1093/hmg/ddx195
   PubMed Web of Science ®Google Scholar
• Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1), 103–141. https://doi.org/10.1016/j.pharmthera.2012.12.007
   PubMed Web of Science ®Google Scholar